MYGN - Myriad Genetics Inc - Insider Stock Trading - OpenInsider

16 results - M - W - D

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
10/11/24 17:23	10/11/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Diaz Paul J	UT	DO	P,CEO	S	-344	22.93	0	-15	-2	962	D
9/12/24 16:11	9/11/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Diaz Paul J	UT	DO	P,CEO	S	-401	26.72	0	-15	-2	977	D
9/12/24 16:09	9/11/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Muzzey Dale	UT	O	Chief Sc	S	-55	26.17	0	-2	-2	108	D
9/9/24 17:48	9/9/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Dreismann Heinrich	UT	D		S	-271	27.05	0	-10	-8	122	D
9/4/24 19:38	9/3/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Reitan Colleen F	UT	D		S	-1,286	27.95	0	-46	-52	43	D
8/23/24 16:16	8/21/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Ancona Margaret	UT	O	SVP,Chie	S	-321	27.82	0	-12	-13	79	D
8/20/24 16:38	8/19/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Kumar Rashmi	UT	D		S	-210	28.01	0	-8	-9	77	D
6/4/24 17:57	6/3/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Spiegelman Daniel K	UT	D		S.m	-167	22.05	0	-8	-19	33	D
5/15/24 17:49	5/13/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Diaz Paul J	UT	DO	P,CEO	S.m	-5,729	25.14	0	-228	-18	1,066	D
5/15/24 17:48	5/13/24	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Newcomer Lee Nisley	UT	D		S	-157	25.30	0	-6	-9	67	D
12/5/23 16:19	12/1/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	S	-573	19.09	0	-30	-9	292	D
11/3/23 17:12	11/1/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	S	-471	15.69	0	-30	-9	322	D
6/2/23 18:15	6/2/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Spiegelman Daniel K	UT	D		S	-199	23.01	0	-9	-18	40	D
3/28/23 17:23	3/27/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lambert Nicole	UT	O	COO	S	-151	23.48	0	-6	-3	241	D
3/3/23 17:07	3/2/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Riggsbee Richard Bryan	UT	O	CFO	S	-338	22.55	0	-15	-4	338	D
3/3/23 17:04	3/2/23	MYGN	Health	Diagn	In Vitro & In Vivo Diagnostic	Lambert Nicole	UT	O	COO	S	-300	22.74	0	-13	-6	215	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact